A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis

N. Ejskjaer, J. M. Wo, T. Esfandyari, M. Mazen Jamal, G. Dimcevski, L. Tarnow, R. A. Malik, P. M. Hellström, E. Mondou, J. Quinn, F. Rousseau, R. W. Mccallum

Research output: Contribution to journalArticle

63 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis'. Together they form a unique fingerprint.

Medicine & Life Sciences